Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship

    Marcela Šafratová, Yu‐Li Chen, Anna Hošťálková, Jakub Chlebek, Chung‐Fan Hsieh, Bing‐Hung Chen, Lucie Cahlíková, Štefan Kosturko, Anders Backlund, Jim‐Tong Horng, Tsong‐Long Hwang, Michal Kořínek
    TLDR Certain alkaloids could help create new coronavirus drugs.
    This study evaluates the antiviral activity of isoquinoline and Amaryllidaceae-type alkaloids against coronaviruses, focusing on their structure–activity relationships. Using Huh7 cancer cells and a lentivirus-based SARS-CoV-2 entry assay, several alkaloids, including haemanthidine, aromoline, and berbamine, showed significant protective effects against human coronavirus 229E. Aromoline was particularly potent against SARS-CoV-2 variants, suggesting its potential as a pan-coronavirus entry inhibitor. The study highlights the favorable safety profiles and drug-like properties of these alkaloids, suggesting their potential for therapeutic development against COVID-19. Molecular docking studies indicate that these compounds interact with the SARS-CoV-2 S-protein, inhibiting virus entry into host cells.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results